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Purpose: With the recent interest on the theranostic 
approach, there has been a renewed interest for alternative 
radionuclides in nuclear medicine. They can be produced 
using common production routes using protons accelerated by 
biomedical cyclotrons or neutrons produced in research 
reactors. However, in some cases, it can be more valuable to 
use deuterons as projectiles.  
The aim of this study is to illustrate the interest of using 
deuterons as projectiles to produce alternative radionuclides 
for medical applications. For that purpose, three examples 
have been chosen according to the fact that these 
radionuclides are produced using deuterons: production of 
Cu-64, Sc-44m and Re-186.  
Materials/methods: For each radionuclide of interest, 
production yields have been calculated using experimental 
data from the literature when they exist or calculated value 
obtained using the TALYS 1.6 code [1] when no experimental 
data is available or for stable element. In some cases, new 
experimental production cross section have been measured 
[2, 3] at our facility [4]. 
Results: New set of cross sections have been obtained for 
natW(d,x)186Re and for 44Ca(d,n)44Sc using the stacked foil 
technique. Thick target yield for deuteron induced and 
proton induced reaction have been calculated and compared 
with yield obtained real production run. 
In the case of Cu-64, smaller quantities of the expensive 
target material, Ni-64, are used with deuterons as compared 
with protons for the same produced activity. For the Sc-
44m/Sc-44g generator, deuterons afford a higher Sc-44m 
production yield than with protons. Finally, in the case of Re-
186g, deuterons lead to a production yield three times higher 
than protons.    
Conclusions: These three examples show that it is of interest 
to consider not only protons or neutrons but also deuterons 
to produce alternative radionuclides. At the Arronax facility 
where deuteron beams are available with energy ranging 
from 15 MeV to 34 MeV, Cu-64 and Sc-44 are produced using 
16 MeV deuterons. In the future Re-186 will also be 
considered for production using deuteron beams.  
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Telomerase reactivation is essential for telomere 
maintenance in human cancer cells ensuring indefinite 
proliferation. Targeting telomere homeostasis has become 
one of the promising strategies in the therapeutic 
management of tumours. One major potential drawback, 
however, is the time lag between telomerase inhibition and 
critically shortened telomeres triggering cell death, allowing 
cancer cells to acquire drug resistance. Dysfunctional 
telomeres, resulting from the loss of telomeric DNA repeats 
or the loss of function of telomere-associated proteins trigger 
DNA damage responses similar to that observed for double 
strand breaks. We have recently shown that inhibition of DNA 
repair protein and telomerase renders cells more sensitive to 
DNA damaging agent. In addition to the disruption of 
telomere length maintenance, telomerase inhibition 
decreased tumour cell viability, induced cell cycle arrest and 
DNA damage. Repair of telomerase inhibitor-induced DNA 
damage involved activation of DNA-PKcs protein with 
inhibition of DNA-PKcs activity causing delay in the repair of 
induced DNA damage. Additionally, telomere dysfunctional 
foci were more detectable in DNA-PKcs deficient cancer cells 
as compared to DNA-PKcs proficient cells. The observed 
therapeutic potential in the cancer tumour cells improved 
when they were combined with the inhibition of certain 
selective DNA repair factors (such as PARP-1 and DNA-PKcs). 
We have also observed the radio-sensitisation potential of 
these telomerase inhibitors in selected human tumour cells. 
Taken together, our in vitro studies in cancer cells 
demonstrate that inhibition of DNA repair pathways and that 
of telomerase could be an alternative strategy to enhance 
anti-tumour effects and circumvent the possibility of drug 
resistance. 
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Radiotherapy plays an important role in the treatment of 
pelvic tumors. The advances in patients’ prognosis come at 
the expense of radiation-induced toxicity. Progressive cell 
depletion and inflammation are the leading mechanisms of 
acute toxicity which is observed during or shortly after 
treatment. The pathogenetic pathways of late toxicity, 
developing 90 days after the onset of radiotherapy, are more 
complex and involve processes such as vascular sclerosis and 
fibrosis. Since many patients have become long-term 
survivors, awareness and recognition of treatment-related 
toxicity has gained in importance and increased efforts are 
made for its prevention and management.  
Technical innovations contribute to a reduction in 
radiotherapy-associated toxicity. The steep dose gradients of 
highly-conformal radiotherapy techniques allow for an 
accurate dose delivery with optimal sparing of the normal 
tissues. Several studies have demonstrated the dosimetrical 
benefit of intensity-modulated radiotherapy (IMRT) and 
volumetric modulated radiotherapy (VMAT) compared to 
